Devendra Desai
Overview
Explore the profile of Devendra Desai including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
71
Citations
415
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Patel P, Desai D, Dharap V, Hodgar D
Am J Gastroenterol
. 2025 Mar;
PMID: 40079480
No abstract available.
2.
Dharap V, Desai D, Abraham P, Gupta T, Dhoble P, Mehta N, et al.
Intest Res
. 2025 Jan;
PMID: 39848333
Background/aims: Sarcopenia is implicated in inflammatory bowel disease (IBD) complications and surgical outcomes. This study aimed to investigate the prevalence and follow-up of sarcopenia in patients with IBD. Methods: Consecutive...
3.
Harindranath S, Desai D
Expert Rev Med Devices
. 2025 Jan;
22(2):121-126.
PMID: 39798078
Introduction: Wearables are electronic devices worn on the body to collect health data. These devices, like smartwatches and patches, use sensors to gather information on various health parameters. This review...
4.
Akyuz F, An Y, Begun J, Aniwan S, Bui H, Chan W, et al.
Intest Res
. 2024 Nov;
23(1):37-55.
PMID: 39492666
The lack of clear definition and classification for "moderate ulcerative colitis (UC)" creates ambiguity regarding the suitability of step-up versus top-down treatment approaches. In this paper, experts address crucial gaps...
5.
Andhale A, Abraham P, Dhoble P, Desai D, Joshi A, Gupta T, et al.
Indian J Gastroenterol
. 2024 Feb;
43(6):1203-1208.
PMID: 38407788
Introduction: The use of proton-pump inhibitors (PPI) is linked with infrequent but serious adverse events, including acute kidney injury, chronic kidney disease (CKD) and progression of CKD. Data on renal...
6.
Banerjee R, Sharma V, Patel R, Jena A, Pal P, Raghunathan N, et al.
Indian J Gastroenterol
. 2024 Feb;
43(1):22-35.
PMID: 38347433
Rising number of inflammatory bowel disease (IBD) cases in developing countries necessitate clear guidance for clinicians for the appropriate use of advanced therapies. An expert consensus document was generated to...
7.
Desai D
Indian J Gastroenterol
. 2024 Feb;
43(1):93-102.
PMID: 38329599
The global burden of inflammatory bowel diseases (IBD) is estimated at 4.9 million and the global prevalence exceeds 0.3%. Multiple newer therapeutic agents have broadened the options for the therapy...
8.
Abraham P, Dhoble P, Desai D, Joshi A, Gupta T
JGH Open
. 2023 Nov;
7(11):772-776.
PMID: 38034051
Background And Aim: Low-fermentable oligo-, di-, and monosaccharides and polyol (FODMAP) diets have been recommended for individuals with food intolerance and irritable bowel syndrome (IBS). Individual food intolerances may, however,...
9.
Desai D, Dhoble P
Indian J Gastroenterol
. 2023 Sep;
43(1):15-17.
PMID: 37773577
No abstract available.
10.
Desai D, Jena A, Sharma V, Hibi T
Expert Rev Clin Pharmacol
. 2023 Jun;
16(7):643-653.
PMID: 37387532
Introduction: Thiopurine toxicity is related to genetic polymorphism. Thiopurine methyltransferase (TPMT) variants do not explain thiopurine toxicity in more than half of patients. Asians, despite the low prevalence of TPMT...